Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality - Quiz - MDSpire

Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality

  • By

  • Joaquín Martínez-López

  • María-Victoria Mateos

  • Cristina Encinas

  • Anna Sureda

  • José Ángel Hernández-Rivas

  • Ana Lopez de la Guía

  • Diego Conde

  • Isabel Krsnik

  • Elena Prieto

  • Rosalía Riaza Grau

  • Mercedes Gironella

  • María Jesús Blanchard

  • Nerea Caminos

  • Carlos Fernández de Larrea

  • María Alicia Senin

  • Fernando Escalante

  • José Enrique de la Puerta

  • Eugenio Giménez

  • Pilar Martínez-Barranco

  • Juan José Mateos

  • Luis Felipe Casado

  • Joan Bladé

  • Juan José Lahuerta

  • Javier de la Cruz

  • Jesús San-Miguel

  • October 19, 2020

  • 0 min

Share

Original Source(s)

Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality

  • by Joaquín Martínez-López, María-Victoria Mateos, Cristina Encinas, Anna Sureda, José Ángel Hernández-Rivas, Ana Lopez de la Guía, Diego Conde, Isabel Krsnik, Elena Prieto, Rosalía Riaza Grau, Mercedes Gironella, María Jesús Blanchard, Nerea Caminos, Carlos Fernández de Larrea, María Alicia Senin, Fernando Escalante, José Enrique de la Puerta, Eugenio Giménez, Pilar Martínez-Barranco, Juan José Mateos, Luis Felipe Casado, Joan Bladé, Juan José Lahuerta, Javier de la Cruz, Jesús San-Miguel

  • October 19, 2020

Related Content

Bridging therapy before CAR-T for multiple myeloma: a survey from the CMWP and CTIWP of the EBMT

Prognostic Impact of Early Disease Progression and Early Mortality in Patients with Multiple Myeloma: A Real-World Cohort Study

Combination of Lisaftoclax, Ixazomib, and Dexamethasone for Maintenance Therapy Following CAR-T in Patients with Transplant-Ineligible Relapsed/Refractory Ultra-High-Risk Multiple Myeloma: A Review of Two Cases and Relevant Literature